Just to be clear, the FDA has only reversed its refusal to review the vaccine for approval; it hasn’t been approved:

In an announcement Wednesday morning, Moderna said the FDA has now agreed to review its vaccine after the company held a formal (Type A) meeting with the FDA and proposed a change to the regulatory pathways used in the application.